National Leading Hospital of the National Rare Disease Diagnosis and Treatment Collaboration Network, host of the National Rare Disease Registration Platform (over 40,000 cases registered in-depth). Chief editor of China's first 'Guidelines for the Diagnosis and Treatment of Rare Diseases'. In February 2024, the first independent specialized ward for rare diseases will be officially launched, with 34 MDT specialty groups for complex diseases, serving as a core national base to address the challenges of 'difficult access to care, difficult diagnosis, and difficult medication'.
With the spirit of 'Centennial Grand Ward Rounds', relying on 34 MDT expert groups, the rare disease specialized ward, and national key laboratories, we achieve a complete loop of 'clinical discovery—gene decoding—basic analysis—targeted therapy'.
Century-Old Heritage · Premier Specialties
National Leading Hospital of the National Rare Disease Diagnosis and Treatment Collaboration Network, host of the National Rare Disease Registration Platform (over 40,000 cases registered in-depth). Chief editor of China's first 'Guidelines for the Diagnosis and Treatment of Rare Diseases'. In February 2024, the first independent specialized ward for rare diseases will be officially launched, with 34 MDT specialty groups for complex diseases, serving as a core national base to address the challenges of 'difficult access to care, difficult diagnosis, and difficult medication'.
With the spirit of 'Centennial Grand Ward Rounds', relying on 34 MDT expert groups, the rare disease specialized ward, and national key laboratories, we achieve a complete loop of 'clinical discovery—gene decoding—basic analysis—targeted therapy'.
Multidisciplinary one-stop care in the independent specialized ward for rare diseases: daily joint ward rounds and interdisciplinary consultations by renowned experts from multiple specialties
Rapid molecular genetic etiology screening channels using whole exome sequencing (WES) and whole genome sequencing (WGS)
National rare disease registration system and multicenter clinical follow-up network, driving clinical trials for new drugs for rare diseases and synchronized international market entry
'Orphan drug' precise medication rapid green approval and long-term multidisciplinary comprehensive functional rehabilitation assessment
34 outpatient MDT specialty groups for complex diseases (covering pituitary, pancreas, musculoskeletal, cardiovascular, thoracic tumors, etc.), serving tens of thousands of patients
Chief Physician, Professor, Doctoral Supervisor
Core Indications & Conditions Treated
National authority in systemic vasculitis and Takayasu arteritis. Specializes in advanced biologic therapy for vasculitis, lupus crises, and pregnancy management in rheumatic disease patients.
Chief Physician, Professor, Doctoral Supervisor
Core Indications & Conditions Treated
Discipline leader in female pelvic medicine and reconstructive surgery in China. Renowned internationally for novel pelvic organ prolapse reconstruction and surgical management of congenital genital malformations.
Chief Physician, Professor, Doctoral Supervisor
Core Indications & Conditions Treated
National pioneer in cerebrospinal fluid (CSF) cytology and neuro-infectious immunology, providing authoritative 'liquid biopsy' diagnostics for encephalitis and meningitis.
Chief Physician, Professor, Doctoral Supervisor
Core Indications & Conditions Treated
Leading expert in neurogenetics and rare neuromuscular diseases, specializing in Fabry disease, Pompe disease, spinal muscular atrophy, and muscular dystrophies.
Chief Physician, Professor, Doctoral Supervisor, Changjiang Scholar
Core Indications & Conditions Treated
President of PUMCH and leading investigator of the National Rare Diseases Registry System. World authority on cardiomyopathy, cardiac amyloidosis (ATTR), Fabry disease, and heart failure management.
Chief Physician, Professor, Doctoral Supervisor
Core Indications & Conditions Treated
Director of Hematology at PUMCH and internationally renowned authority on POEMS syndrome and systemic AL amyloidosis, authoring definitive global clinical criteria.
Chief Physician, Professor, Doctoral Supervisor
Core Indications & Conditions Treated
National leader in rare tubular and tubulointerstitial kidney disorders, establishing China's Gitelman and Bartter syndrome clinical and genetic registry.
Independent support for patients seeking care at PUMCH
Century-Old Heritage · Premier Specialties
